Lead sponsor
Biomed Industries, Inc.
3 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
3
Trials led
1
Active
424
Total enrollment
22
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Phase 2
2
Trials by status
Not yet recruiting
1
Completed
2
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or ObeseBMI ≥30Ph 2Not yet recruiting224